Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.37 |
| ▸ | TACR1 | P25103 | 7/20 | 0.37 |
| ▸ | TSPO | P30536 | 1/20 | 0.36 |
| ▸ | ICMT | O60725 | 1/20 | 0.33 |
| ▸ | METAP2 | P50579 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22157606 | 0.96 | KIF11 (0.40) | KIF11TACR1ICMTMETAP2GLO1 | |
| SCHEMBL22157616 | 0.93 | KIF11 (0.38) | KIF11TACR1METAP2MGAMGAA | |
| SCHEMBL22156620 | 0.90 | ABCG2 (0.35) | KIF11TACR1MGAMGAASI | |
| SCHEMBL22158642 | 0.89 | TACR1 (0.36) | KIF11TACR1TSPOICMTTDP1 | |
| SCHEMBL22157612 | 0.89 | KIF11 (0.40) | KIF11TACR1METAP2MGAMGAA | |
| SCHEMBL22156026 | 0.88 | CYP11B1 (0.36) | TACR1METAP2TDP1 | |
| SCHEMBL22157750 | 0.88 | CYP11B2 (0.35) | KIF11TACR1MGAMGAASI | |
| SCHEMBL22157448 | 0.87 | TACR1 (0.36) | KIF11TACR1TSPOICMTMETAP2 | |
| SCHEMBL22157614 | 0.86 | KIF11 (0.38) | KIF11TACR1HSP90AA1ALDH1A1 | |
| SCHEMBL22157605 | 0.86 | KIF11 (0.38) | KIF11TACR1HSP90AA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, OR51E2 | KIF11 4485/4885TACR1 936/4885TSPO 499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.